Company: JUNS
Filing Date: 2025-11-06
Form Type: DEF 14A
Source: 0001493152-25-020988
Chunk: 11

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-06
Form: DEF 14A
Chunk 11
---
 my vote confidential?

Yes, your vote is confidential. Only the inspector of elections, individuals who help with processing and counting your votes and persons who need access for legal reasons will have access to your vote. This information will not be disclosed, except as required by law.

What constitutes a quorum?

To carry on business at the virtual Annual Meeting, we must have a quorum. A quorum is present when a majority of the voting power, as of the Record Date, are represented in person or by proxy. Thus, the holders of shares must be represented in person or by proxy to have a quorum at the virtual Annual Meeting. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. Shares owned by us are not considered outstanding or considered to be present at the virtual Annual Meeting. If there is not a quorum at the Annual Meeting, either the chairperson of the virtual Annual Meeting or our stockholders entitled to vote at the Annual Meeting may adjourn the Annual Meeting.

| -5- |

How will my shares be voted if I give no specific instruction?

We must vote your shares as you have instructed. If there is a matter on which a stockholder of record has given no specific instruction but has authorized us generally to vote the shares, they will be voted as follows:

1. To elect seven (7) directors, the names of whom are set forth in the accompanying Proxy Statement, each to serve until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified;

2. To approve an amendment to the Company’s certificate of incorporation to increase the authorized shares of Common Stock available for issuance from 125,000,000 shares to 500,000,000 shares;

3. To adopt the Jupiter Neurosciences, Inc. 2025 Equity Incentive Plan;

4. To ratify the selection of Cherry Bekaert as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;

5. To approve, for purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(d), the potential issuance of shares of Common Stock, in excess of 19.99% or more of the Company’s issued and outstanding Common Stock of up to $20 million